Gene · 51428
Papers1,824
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,824
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Makishima H, Saiki R, Nannya Y, et al. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood. 2023;141(5):534-549. | Blood | 2024 | 38696198 | PubTator, text mining | PubMed |
| Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations. | Hematology | 2024 | 38597818 | PubTator, text mining | PubMed |
| Impaired binding affinity of YTHDC1 with METTL3/METTL14 results in R-loop accumulation in myelodysplastic neoplasms with DDX41 mutation. | Leukemia | 2024 | 38514771 | PubTator, text mining | PubMed |
| Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines. | Int J Hematol | 2024 | 38492200 | PubTator, text mining | PubMed |
| Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders. | Best Pract Res Clin Haematol | 2024 | 38490765 | PubTator, text mining | PubMed |
| Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens. | Leukemia | 2024 | 38368440 | PubTator, text mining | PubMed |
| DDX41: exploring the roles of a versatile helicase. | Biochem Soc Trans | 2024 | 38348889 | PubTator, text mining | PubMed |
| Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia. | Heliyon | 2024 | 38312561 | PubTator, text mining | PubMed |
| The clinical characteristics, gene mutations and outcomes of myelodysplastic syndromes with diabetes mellitus. | J Cancer Res Clin Oncol | 2024 | 38305890 | PubTator, text mining | PubMed |
| Protocol for detection of in vitro R-loop formation using dot blots. | STAR Protoc | 2024 | 38285737 | PubTator, text mining | PubMed |
| Spliceosomal helicases DDX41/SACY-1 and PRP22/MOG-5 both contribute to proofreading against proximal 3' splice site usage. | RNA | 2024 | 38282418 | PubTator, text mining | PubMed |
| Diversity of amyloid beta peptide actions. | Rev Neurosci | 2024 | 38281140 | PubTator, text mining | PubMed |
| Broad Spectrum Enantioselective Amide Bond Synthetase from Streptoalloteichus hindustanus. | ACS Catal | 2024 | 38269041 | PubTator, text mining | PubMed |
| Interventions to de-implement unnecessary antibiotic prescribing for ear infections (DISAPEAR Trial): protocol for a cluster-randomized trial. | BMC Infect Dis | 2024 | 38267837 | PubTator, text mining | PubMed |
| Necroptosis in Pneumonia: Therapeutic Strategies and Future Perspectives. | Viruses | 2024 | 38257794 | PubTator, text mining | PubMed |
| A Rare Benzothiazole Glucoside as a Derivative of 'Albedo Bluing' Substance in Citrus Fruit and Its Antioxidant Activity. | Molecules | 2024 | 38257215 | PubTator, text mining | PubMed |
| Endothelial leakiness elicited by amyloid protein aggregation. | Nat Commun | 2024 | 38242873 | PubTator, text mining | PubMed |
| Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation. | Leukemia | 2024 | 38238444 | PubTator, text mining | PubMed |
| MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease. | J Transl Med | 2024 | 38229084 | PubTator, text mining | PubMed |
| Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy. | Heliyon | 2024 | 38223723 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51428/papers?page=8